Plan sponsors’ overall satisfaction with their PBMs increased
from 8.0 on a 1-10 scale in 2020 to 8.2 in 2021, according to Pharmaceutical
Strategies Group’s 2021 Pharmacy Benefit Manager Customer Satisfaction Report.
Based on surveys completed by 291 plan sponsors who provide pharmacy benefits
to their employees, the report found that PBMs with 20 million or fewer members
tend to have higher satisfaction ratings than larger PBMs. Average satisfaction
was highest for PBMs’ opioid management programs, while gene therapy financial
protection programs rated the lowest and only 13% of the respondents used such
programs. Among PBMs with more than 20 million members, MedImpact scored the
highest overall satisfaction rate (8.5).

No comments:
Post a Comment